Glenmark Initiates Phase 3 Clinical Trials On Favipiravir

Glenmark Pharmaceuticals has begun Phase 3 of clinical trials on antiviral drug Favipiravir to check its efficacy on COVID-19 patients, reports PTI. The company said that it has commenced clinical trials and 10 public and private hospitals have enrolled in the trial.